Latest News
Group asks FDA to pull birth control patch off market
Arguing that it's a far riskier treatment than the pill, consumer advocacy group Public Citizen has asked the FDA to pull the birth control patch Ortho-Evra off the market. Over the last few years, Read more...
Trend: Physician recruiting affected by real estate market
This may not come as much of a shock, but it's still worth mentioning: According to new research by a recruiting firm, the ongoing real estate crisis is having a significant impact on physician Read more...
Suicide risk may be higher for MDs
While many inside the profession don't like to discuss the issue, it's getting publicity nonetheless: Doctors are killing themselves at comparatively high rates. While exact statistics are hard to Read more...
Case study: Kaiser physicians go on sales calls
It's not often that prospective health plan members get pitched directly by a physician. But at Kaiser Permanente Colorado, that's exactly what's happening. The HMO has launched a program under which Read more...
Case study: TX trauma hospital faces neurosurgery crisis
In a situation echoed in emergency departments around the country, the ED at Harris Methodist Fort Worth Hospital has been turning away patients with brain and spine injuries for months due to a Read more...
SPOTLIGHT: New rules would limit Medicare marketing
Federal regulators have proposed new rules that would set limits on the marketing of private Medicare health plans. The rules would ban unsolicited sales visits and phone calls to beneficiaries, Read more...
ALSO NOTED: Plavix copycat on the rise in Europe; Hospital bills for services to dead patient; and much more...
> Pharma giants Sanofi-Aventis and Bristol-Myers Squibb are preparing to battle a copycat generic to its Plavix brand. Read more...
Harvard Med offers tuition discount
Harvard Medical School, the ultimate elite educational institution, will begin offering a discount on its tuition to some students, a step that observers say may ripple out into other institutions. Read more...
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies





